Study guide

5.4 HELLP Syndrome & Hepatic Crisis Management

C-OBE Obstetric Emergencies Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Maternal Assessment, Risk Stratification & Early Warning Systems

1.1 Pre-Existing Medical, Surgical & Obstetric Comorbidities in Emergency Risk Stratification 1.2 Dynamic Antepartum & Intrapartum Risk Assessment 1.3 Maternal Early Warning Systems (MEWS/MEWT) & Critical Triage Physical Assessment 1.4 Alliance for Innovation on Maternal Health (AIM) Safety Bundles & Emergency Readiness

2 Chapter 2: Obstetric Hemorrhage — Etiology, Assessment & Uterotonics

2.1 Postpartum Hemorrhage Etiology (4 T's) & Quantitative Blood Loss (QBL) 2.2 Uterotonic Pharmacology & Stepwise Administration Protocols 2.3 Tranexamic Acid (TXA) Protocols & Hemorrhage Timing

3 Chapter 3: Obstetric Hemorrhage — Mechanical Interventions, Placental Disorders & Transfusion

3.1 Intrauterine Tamponade Balloons, Compression Sutures & Surgical Hemostasis 3.2 Ectopic Pregnancy, Placenta Previa, Accreta Spectrum (PAS), Abruption & Vasa Previa 3.3 Obstetric DIC, Coagulopathy & Massive Transfusion Protocol (MTP)

4 Chapter 4: Hypertensive Disorders of Pregnancy & Preeclampsia with Severe Features

4.1 Classification & Spectrum of Hypertensive Disorders of Pregnancy 4.2 Preeclampsia with Severe Features: Pathophysiology & End-Organ Damage 4.3 Diagnostic Evaluation, Laboratory Triggers & Fetal Surveillance in Preeclampsia

5 Chapter 5: Hypertensive Crisis, Eclampsia & Magnesium Sulfate Therapy

5.1 Acute Severe Hypertension & First-Line Antihypertensive Protocols 5.2 Eclampsia Recognition, Seizure Management & Airway Protection 5.3 Magnesium Sulfate Neuroprotection/Seizure Prophylaxis Protocols, Monitoring & Toxicity Reversal 5.4 HELLP Syndrome & Hepatic Crisis Management

6 Chapter 6: Maternal Resuscitation, Cardiac Arrest & Perimortem Cesarean

6.1 Maternal ACLS Modifications & Cardiopulmonary Resuscitation Physiology 6.2 Etiologies of Maternal Arrest & Structured Emergency Response 6.3 Perimortem Cesarean Delivery (PMCD / Resuscitative Hysterotomy)

7 Chapter 7: Amniotic Fluid Embolism & Maternal Shock States

7.1 Amniotic Fluid Embolism (AFE): Pathophysiology & Clinical Presentation 7.2 A-OK Protocol, Hemodynamic Support & Critical Care in AFE 7.3 Maternal Shock States: Hemorrhagic, Distributive, Cardiogenic & Obstructive

8 Chapter 8: Acute Intrapartum Delivery Emergencies

8.1 Shoulder Dystocia: Recognition, Timing & Primary HELPERR Sequence 8.2 Advanced Shoulder Dystocia Maneuvers & Neonatal Brachial Plexus Injury Prevention 8.3 Umbilical Cord Prolapse Recognition & Emergent Decompression Protocols

9 Chapter 9: Uterine Inversion, Malpresentation & Obstetric Trauma

9.1 Acute Uterine Inversion: Recognition, Tocolysis & Manual/Surgical Reduction 9.2 Emergency Vaginal Breech Extraction & Head Entrapment Maneuvers 9.3 Maternal Trauma: Primary/Secondary Survey, Placental Abruption & Fetomaternal Hemorrhage

10 Chapter 10: Maternal Sepsis, Intraamniotic Infection & Severe Infections

10.1 Maternal Sepsis: Physiological Criteria, S.O.S. Score & omSOFA 10.2 The Maternal Sepsis Hour-1 Bundle & Fluid/Vasopressor Optimization 10.3 Intraamniotic Infection (Triple I / Chorioamnionitis) & Severe Endometritis 10.4 Severe Pyelonephritis, Maternal Pneumonia & Severe Peripartum Infections

11 Chapter 11: Endocrine, Cardiovascular, Respiratory & Neurologic Emergencies

11.1 Diabetic Ketoacidosis (DKA), Maternal Hypoglycemia & Endocrine Resuscitation in Pregnancy 11.2 Peripartum Cardiomyopathy (PPCM), Acute Heart Failure, Acute Coronary Syndromes & Maternal Arrhythmias 11.3 Status Asthmaticus, Pulmonary Edema & ARDS in Pregnancy 11.4 Status Epilepticus, Acute Stroke & Cerebral Venous Sinus Thrombosis (CVST)

12 Chapter 12: Thromboembolism, Hepatorenal Disorders & Toxicologic Emergencies

12.1 Venous Thromboembolism (DVT/PE) Diagnosis, Treatment & Peripartum Anticoagulation 12.2 Acute Fatty Liver of Pregnancy (AFLP / Swansea Criteria) & Acute Kidney Injury 12.3 Peripartum Substance Overdose, Opioid Toxicity & Naloxone Administration

13 Chapter 13: Obstetric Anesthesia Emergencies & Critical Complications

13.1 High Spinal / Total Spinal Anesthesia & Aspiration Pneumonitis 13.2 Local Anesthetic Systemic Toxicity (LAST) & 20% Lipid Emulsion Rescue Protocol 13.3 Post-Dural Puncture Headache (PDPH), Epidural Hematoma & Abscess 13.4 Malignant Hyperthermia in Obstetric Anesthesia & Dantrolene Protocol

14 Chapter 14: Professional Practice, Team Communication, Debriefing & Health Equity

14.1 Crisis Resource Management (CRM), TeamSTEPPS & Structured Communication 14.2 Multidisciplinary Emergency Debriefing, Morbidity & Mortality, and Systems Learning 14.3 Perinatal Racial/Ethnic Disparities, Implicit Bias Mitigation & Respectful Maternity Care 14.4 Legal, Ethical, Documentation & EMTALA Standards in Obstetric Emergencies

5.4 HELLP Syndrome & Hepatic Crisis Management

Key Takeaways Explain This Topic AI

HELLP syndrome is a severe variant of preeclampsia characterized by microangiopathic hemolytic anemia, elevated liver enzymes, and low platelets; the gold-standard Tennessee criteria mandate: Hemolysis (schistocytes on blood smear, LDH >600 IU/L, total bilirubin >=1.2 mg/dL), Elevated Liver enzymes (AST >=70 IU/L), and Low Platelets (<100,000/mcL).

The Mississippi Triple-Class system stratifies disease severity and maternal-fetal risk based on platelet nadir: Class 1 (<50,000/mcL; highest mortality and bleeding risk), Class 2 (50,000 to <100,000/mcL), and Class 3 (100,000 to 150,000/mcL with LDH >600 and AST >=40).

Hepatic subcapsular hematoma and rupture represent rare, life-threatening complications manifesting as acute-onset severe right upper quadrant/epigastric pain radiating to the right shoulder, refractory hypotension, and hypovolemic shock; immediate diagnostic evaluation requires emergent point-of-care ultrasound (FAST) or contrast CT.

Hemodynamically stable patients with unruptured, contained subcapsular hematomas are managed non-operatively with intensive ICU surveillance, correction of coagulopathy, and serial imaging; active hepatic rupture or hemoperitoneum requires immediate damage-control surgery (perihepatic packing) or transcatheter hepatic arterial embolization (TAE).

Platelet transfusion is indicated for active bleeding, prior to cesarean delivery if platelets are <50,000/mcL, or prior to neuraxial anesthesia if platelets are <70,000-80,000/mcL; definitive treatment is delivery, initiated without delay after maternal stabilization at >=34 weeks, or following 24-48 hours of corticosteroid stabilization between 24 and 34 weeks in the absence of maternal-fetal decompensation.

Last updated: August 2026

HELLP Syndrome & Hepatic Crisis Management

HELLP syndrome—an acronym for H emolysis, E levated L iver enzymes, and L ow P latelets—is a severe, life-threatening form of preeclampsia characterized by systemic microvascular endothelial injury, platelet activation and consumption, and microvascular fibrin deposition in hepatic sinusoids. It occurs in approximately 0.5% to 0.9% of all pregnancies and in 10% to 20% of cases of preeclampsia with severe features. HELLP syndrome carries substantial maternal risks, including disseminated intravascular coagulation (DIC; 20%), placental abruption (16%), acute renal failure (8%), pulmonary edema (6%), subcapsular liver hematoma/rupture (1%), and maternal mortality (1–3%).

1. Pathophysiology of Microangiopathy & Hepatic Necrosis

The central pathological driver of HELLP syndrome is widespread microvascular endothelial damage triggered by circulating placenta-derived anti-angiogenic factors:

Microangiopathic Hemolytic Anemia (MAHA): Endothelial denudation and intravascular fibrin meshwork formation cause mechanical fragmentation of erythrocytes as they traverse narrowed, turbulent capillary beds. This shearing produces characteristic schistocytes, burr cells, and helmet cells on peripheral blood smears, releasing intracellular lactate dehydrogenase (LDH) and free hemoglobin, which binds and depletes serum haptoglobin.

Consumptive Thrombocytopenia: Extensive endothelial repair leads to continuous platelet adhesion, aggregation, and consumption, shortening platelet lifespan and dropping platelet counts.

Sinusoidal Fibrin Deposition & Periportal Necrosis: Fibrin thrombi deposit within hepatic sinusoids, causing sinusoidal obstruction, intrahepatic vascular congestion, elevated sinusoidal pressure, localized ischemia, and patchy periportal hepatocyte necrosis. This produces marked elevations in serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT).

Glisson's Capsule Distension & Subcapsular Hematoma: Continued sinusoidal bleeding dissects beneath the liver capsule, forming a subcapsular hematoma. Increased intrahepatic pressure or minimal abdominal trauma can precipitate catastrophic capsular rupture and massive hemoperitoneum.

2. Diagnostic Criteria: Tennessee vs. Mississippi Classifications

Two major diagnostic classification frameworks are utilized in clinical practice: +---------------------------------------------------------------------------------------------------+

  • | TENNESSEE CRITERIA (COMPLETE / STRICT HELLP) |
  • | |
  • | 1. HEMOLYSIS (Requires at least TWO of the following): |
  • | • Abnormal peripheral blood smear showing schistocytes, burr cells, or helmet cells. |
  • | • Serum Lactate Dehydrogenase (LDH) > 600 IU/L. |
  • | • Total Serum Bilirubin >= 1.2 mg/dL (in the absence of underlying liver disease). |
  • | • Undetectable / low serum haptoglobin (<25 mg/dL). |
  • | |
  • | 2. ELEVATED LIVER ENZYMES: |
  • | • Serum Aspartate Aminotransferase (AST) >= 70 IU/L (or >2x upper limit of normal). |
  • | • Serum Alanine Aminotransferase (ALT) >= 50–70 IU/L. |
  • | |
  • | 3. LOW PLATELETS: |
  • | • Platelet count < 100,000 / mcL (<100 x 10^9 / L). |
  • | |
  • | * Note: Partial / Incomplete HELLP (e.g., ELLP or LP) meets 1 or 2 criteria but carries high |
  • | risk of progressing rapidly to complete HELLP. |
  • +---------------------------------------------------------------------------------------------------+
  • Mississippi Triple-Class System

The Mississippi classification stratifies HELLP severity based on the patient's nadir platelet count , which correlates directly with maternal morbidity, multi-organ dysfunction, and recovery trajectory:

Mississippi Class Platelet Nadir Threshold Transaminase (AST/ALT) & LDH Criteria Clinical Morbidity & Risk Profile

Class 1 (Severe / High Risk) Platelets < 50 , 000 /mcL <50,000\text{/mcL} < 50 , 000 /mcL ( < 50 × 10 9 /L <50\times 10^9\text{/L} < 50 × 1 0 9 /L ) AST or ALT ≥ 70 IU/L \text{AST or ALT} \ge 70\text{ IU/L} AST or ALT ≥ 70 IU/L ; LDH > 600 IU/L \text{LDH} > 600\text{ IU/L} LDH > 600 IU/L Highest risk of DIC, acute kidney injury, pulmonary edema, liver rupture, and maternal mortality.

Class 2 (Moderate / Intermediate) Platelets 50 , 000 to < 100 , 000 /mcL 50,000\text{ to }<100,000\text{/mcL} 50 , 000 to < 100 , 000 /mcL AST or ALT ≥ 70 IU/L \text{AST or ALT} \ge 70\text{ IU/L} AST or ALT ≥ 70 IU/L ; LDH > 600 IU/L \text{LDH} > 600\text{ IU/L} LDH > 600 IU/L Moderate morbidity; requires immediate stabilization and prompt delivery.

Class 3 (Mild / Incipient) Platelets 100 , 000 to 150 , 000 /mcL 100,000\text{ to }150,000\text{/mcL} 100 , 000 to 150 , 000 /mcL AST or ALT ≥ 40 IU/L \text{AST or ALT} \ge 40\text{ IU/L} AST or ALT ≥ 40 IU/L ; LDH > 600 IU/L \text{LDH} > 600\text{ IU/L} LDH > 600 IU/L Incipient HELLP; close monitoring required; high rate of escalation to Class 1/2.

3. Differential Diagnosis of Microangiopathic & Hepatic Emergencies

HELLP syndrome frequently mimics and must be differentiated from other critical medical and hematologic disorders occurring in late pregnancy:

Feature / Disorder HELLP Syndrome Acute Fatty Liver of Pregnancy (AFLP) Thrombotic Thrombocytopenic Purpura (TTP) Atypical Hemolytic Uremic Syndrome (aHUS)

Primary Pathology Microvascular endothelial activation & sinusoidal thrombosis Defective mitochondrial fatty acid oxidation (LCHAD deficiency) Severe ADAMTS13 deficiency ( < 10 % <10\% < 10% ) leading to ultra-large vWF multimers Uncontrolled alternative complement pathway dysregulation

Hypertension & Proteinuria Present in > 85 % >85\% > 85% of cases Variable / Mild (present in 50%) Variable (often absent) Common / Severe

Hypoglycemia & Ammonia Normal glucose; Normal ammonia Profound Hypoglycemia ( < 50 mg/dL <50\text{ mg/dL} < 50 mg/dL ); Elevated Ammonia Normal glucose; Normal ammonia Normal glucose; Normal ammonia

Coagulopathy (PT/INR, Fibrinogen) Normal until advanced DIC ensues Severe early coagulopathy (Profoundly low fibrinogen, high INR) Normal PT/INR and normal fibrinogen Normal PT/INR; Normal fibrinogen

Transaminases (AST/ALT) Moderately elevated ( 100 – 1 , 000 IU/L 100\text{--}1,000\text{ IU/L} 100 – 1 , 000 IU/L ) Markedly elevated ( 300 – 1 , 000 + IU/L 300\text{--}1,000+\text{ IU/L} 300 – 1 , 000 + IU/L ) Normal or minimally elevated Normal or minimally elevated

Renal vs. Neurological Focus Variable renal impairment Acute renal failure common Severe fluctuating neurological signs (coma, stroke, seizures) Severe acute anuric renal failure

Definitive Treatment Delivery & supportive care Immediate delivery & ICU glucose/plasma support Therapeutic Plasma Exchange (TPE) Complement inhibitor (Eculizumab / Ravulizumab)

4. Hepatic Subcapsular Hematoma & Rupture

Hepatic subcapsular hematoma and parenchymal rupture represent the most catastrophic hepatic complications of HELLP syndrome, occurring in approximately 1 in 40,000 to 1 in 250,000 pregnancies, with maternal-fetal mortality historically reaching 20% to 50%.

Clinical Presentation & The Classic Triad

Acute Triad: Sudden, severe right upper quadrant (RUQ) or epigastric pain radiating to the right shoulder/neck ( Kehr's sign due to diaphragmatic peritoneal irritation), acute abdominal distension, and rapid progression to hypovolemic shock / profound hypotension .

Precipitating Factors: Spontaneous rupture, minor abdominal trauma, vigorous palpation, or increased intra-abdominal pressure during labor contractions or operative delivery. +---------------------------------------------------------------------------------------------------+

  • | HEPATIC CRISIS EMERGENCY MANAGEMENT PATHWAY |
  • | |
  • | 1. IMMEDIATE DIAGNOSTIC IMAGING: |
  • | • Bedside Point-of-Care Ultrasound (POCUS / FAST Exam): Immediate bedside detection of free |
  • | fluid (hemoperitoneum) in Morison's pouch and the pelvis. |
  • | • Contrast-Enhanced Abdominal CT: Modality of choice in hemodynamically STABILIZED patients |
  • | to delineate hematoma size, parenchymal depth, and active arterial extravasation ("blush"). |
  • | |
  • | 2. HEMODYNAMIC RESUSCITATION & COAGULOPATHY CORRECTION: |
  • | • Activate Massive Transfusion Protocol (MTP; 1:1:1 ratio PRBCs, FFP, Platelets). |
  • | • Administer IV Cryoprecipitate if Fibrinogen <150–200 mg/dL. |
  • | • Initiate IV Magnesium Sulfate for seizure prophylaxis and neuroprotection. |
  • | |
  • | 3. STABLE CONTAINED HEMATOMA (UNRUPTURED CAPSULE): |
  • | • Non-operative management in Surgical/Obstetric ICU. |
  • | • Strict bed rest; serial hematocrits and coagulation labs every 2–4 hours. |
  • | • STRICT AVOIDANCE OF ABDOMINAL PALPATION, LEOPOLD MANEUVERS, OR FUNDAL PRESSURE. |
  • | |
  • | 4. ACTIVE EXTRAVASATION / HEMODYNAMICALLY STABLE: |
  • | • Transcatheter Hepatic Arterial Embolization (TAE) by Interventional Radiology (IR). |
  • | |
  • | 5. ACTIVE RUPTURE / HEMODYNAMIC COLLAPSE / HEMOPERITONEUM: |
  • | • Immediate Emergency Damage-Control Laparotomy with Trauma / Hepatobiliary Surgery. |
  • | • Perihepatic surgical packing (4 quadrants), topical hemostatics (fibrin sealants, thrombin),|
  • | temporary abdominal closure (open abdomen / negative pressure therapy). |
  • | • Pringle maneuver (cross-clamping hepatoduodenal ligament) to control inflow bleeding. |
  • | • Liver Transplantation evaluation if parenchymal necrosis is extensive or liver fails. |
  • +---------------------------------------------------------------------------------------------------+
  • 5. Platelet Transfusion Thresholds & Neuraxial Anesthesia Safety

Thrombocytopenia in HELLP syndrome requires clear, protocolized transfusion thresholds before operative interventions: +---------------------------------------------------------------------------------------------------+

  • | HELLP SYNDROME PLATELET TRANSFUSION GUIDELINES |
  • | |
  • | • VAGINAL DELIVERY: |
  • | Transfusion generally not required unless active bleeding is present or count <20,000/mcL. |
  • | |
  • | • CESAREAN DELIVERY: |
  • | Transfuse 1 apheresis unit of platelets (or 6 pooled units) if count is <50,000/mcL |
  • | immediately prior to skin incision (target count >=50,000/mcL for surgical hemostasis). |
  • | |
  • | • NEURAXIAL ANESTHESIA (SPINAL / EPIDURAL): |
  • | • Platelets >= 70,000–80,000/mcL: Generally acceptable for neuraxial placement in the absence |
  • | of rapidly falling counts or platelet dysfunction. |
  • | • Platelets < 70,000/mcL: Neuraxial anesthesia is CONTRAINDICATED due to the catastrophic risk |
  • | of epidural/spinal hematoma and permanent spinal cord compression. General anesthesia is |
  • | the method of choice. |
  • +---------------------------------------------------------------------------------------------------+
  • 6. Obstetric Delivery Timing & Corticosteroid Protocols

Definitive Treatment: Delivery of the fetus and placenta is the only definitive resolution of HELLP syndrome.

Gestational Age Stratification:

≥ 34 0/7 weeks \ge 34\text{ 0/7 weeks} ≥ 34 0/7 weeks of Gestation: Delivery is indicated immediately following maternal hemodynamic and hematologic stabilization.

< 34 0/7 weeks <34\text{ 0/7 weeks} < 34 0/7 weeks of Gestation: If maternal and fetal status remain stable, delivery may be deferred for 24 to 48 hours to allow completion of a course of antenatal corticosteroids ( Betamethasone 12 mg IM Q24H x 2 doses ) for fetal lung maturity and neonatal organ protection.

Immediate Delivery regardless of Gestational Age: Mandatory if any of the following occur: DIC, multiorgan failure, renal failure, liver hematoma/rupture, placental abruption, eclampsia, or non-reassuring fetal status.

Postpartum Course: Platelet counts typically reach their nadir at 24 to 48 hours postpartum , followed by spontaneous recovery and normalization by postpartum day 4 to 6. Transaminases and LDH usually peak within 24 to 48 hours postpartum and steadily decline.

Loading diagram... HELLP Syndrome Diagnostic & Hepatic Crisis Management Algorithm